| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_86fbf2de0c140c14fa8e3e83dfbde41b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c7fd38ff393036b78f4fa402ddeeae2d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4ab2d714181eae13dd7cdead6e6fdaf3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1dadb93a0714bbd9b48f6411be3c9637
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_57a153ba5b0cc19723f76a7ec21c0eec
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8a426b068545671a1d02fed270b5c980 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-3955
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2851
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2803
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-705
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-70503
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-705 |
| filingDate |
2010-03-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2013-04-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cc2302051e83a10d75b47a14245246ea
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_06f013692cb2ae2b721f2a526f9ab4fa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_665cebc06ba1a4064723be81a6ca162c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e3b90d21b0ab8d0475b7c99954a1b1c0 |
| publicationDate |
2013-04-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-8420092-B2 |
| titleOfInvention |
Method of treating diabetes by administering an anti-NKp46 antibody |
| abstract |
The invention relates to use of the natural cytotoxicity receptor NKp46 for preventing and treating diabetes, including type I diabetes (TID) and type 2 diabetes. In particular, the invention provides compositions comprising a fragment of the extracellular region of NKp46 for preventing the onset and progression of diabetes. |
| priorityDate |
2009-03-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |